Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022	Mar. 31, 2021
ASSETS
Cash and cash equivalents	$ 7,670	$ 8,195
Restricted cash and cash equivalents	2,065	1,957
Investments in marketable securities	4,953	4,820
Finance receivables, net of allowance for credit losses of $1,246 and $1,178	82,432	79,192
Investments in operating leases, net	35,455	37,091
Other assets	2,466	2,473
Total assets	135,041	133,728
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	109,152	109,725
Deferred income taxes	1,564	2,860
Other liabilities	6,224	5,548
Total liabilities	116,940	118,133
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at March 31, 2022 and 2021	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive (loss) income	(21)	8
Retained earnings	17,205	14,670
Total shareholder's equity	18,101	15,595
Total liabilities and shareholder's equity	$ 135,041	$ 133,728